We are live on ! Find out more
SRNE

Sorrento Therapeutics, Inc.
SRNE

Delisted

SRNE was delisted on the 22nd of February, 2023.

Back to rankings

9 hedge funds and large institutions have $6.42K invested in Sorrento Therapeutics, Inc. in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 9 → 9 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

75% less capital invested

Capital invested by funds: $26.1K → $6.42K (-$19.6K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAS
Coppell Advisory Solutions
Texas
+$89

Top Sellers

Rank Fund Capital Flow
1
HNB
Huntington National Bank
Ohio
-$94
2
CFGS
Concourse Financial Group Securities
Alabama
-$8

SRNE Hedge Fund Activity: Q3 2023 in Review

9 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q3 2023, worth a combined $6.42K — down 75% from $26.1K a quarter earlier.

Fund positioning in SRNE was balanced in Q3 2023: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.

The largest buyer was Coppell Advisory Solutions, opening a new position worth an estimated $89. The largest seller was Huntington National Bank, cutting an estimated $94.

  • 9 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $6.42K of Sorrento Therapeutics, Inc. stock for Q3 2023, down 75% quarter-over-quarter.
  • 2 funds opened new Sorrento Therapeutics, Inc. positions in Q3 2023 and 2 closed out, a net change of 0 holders.
  • The largest Sorrento Therapeutics, Inc. buyer in Q3 2023 was Coppell Advisory Solutions, an estimated $89 added.
  • The largest Sorrento Therapeutics, Inc. seller in Q3 2023 was Huntington National Bank, an estimated $94 sold.

Based on aggregated 13F filings for Q3 2023.